Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Current Opinion in Pharmacology|June 26, 2013
Targeting MET: why, where and how?Elena Ghiso, Silvia GiordanoCancer Research|December 17, 2008
MicroRNAs impair MET-mediated invasive growthCristina Migliore, Annalisa Petrelli, Elena Ghiso, et al.Cancer Research|September 16, 2010
MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitorsVirna Cepero, J Rafael Sierra, Simona Corso, et al.Molecular Cancer|May 27, 2010
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibitionSimona Corso, Elena Ghiso, Virna Cepero, et al.Neoplasia (New York, N.Y.)|November 15, 2017
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLCElena Ghiso, Cristina Migliore, Vito Ciciriello, et al.Hepatology (Baltimore, Md.)|March 11, 2011
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in miceMarta A Kowalik, Christian Saliba, Monica Pibiri, et al.Journal of Hepatology|July 11, 2014
YAP activation is an early event and a potential therapeutic target in liver cancer developmentAndrea Perra, Marta Anna Kowalik, Elena Ghiso, et al.EMBO Molecular Medicine|July 20, 2018
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signalingCristina Migliore, Elena Morando, Elena Ghiso, et al.Journal of Hepatology|March 1, 2011
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3Vera P Leoni, Giovanna M Ledda-Columbano, Monica Pibiri, et al.Pageof 1